We are delighted to introduce you to our new RSC Pharmaceutics Editorial Board member, Dr Francesca Taraballi.
Dr Taraballi is currently Associate Professor, Director at the Center for Musculoskeletal Regeneration, Houston Methodist Research Institute, USA.
Dr. Francesca Taraballi is a leading expert in translational nanomedicine and immunoengineering, with a strong focus on the clinical scalability of drug delivery systems. Her research bridges material science and immunology to develop smart biomaterials for regenerative medicine and oncology. A core aspect of her work centers on the design, optimization, and GMP-compliant scale-up of nanoparticle platforms—particularly lipid-based systems—for RNA and small molecule delivery. She has extensive experience in navigating regulatory pathways and implementing manufacturing workflows for first-in-human trials, contributing to the development of hospital-based models for personalized therapeutics.
Read some of Dr Taraballi’s research:
RNA therapies for musculoskeletal conditions
Chiara Mancino, Madeline Franke, Antonietta Greco, Tarun Sontam, Patrick Mcculloch, Claudia Corbo, Francesca Taraballi
Journal of Controlled Release, 2025, 377, 756–766
Harnessing RNA Technology to Advance Therapeutic Vaccine Antigens against Chagas Disease
Chiara Mancino, Jeroen Pollet, Assaf Zinger, Kathryn M. Jones, Maria José Villar, Ana Carolina Leao, Rakesh Adhikari, Leroy Versteeg, Rakhi Tyagi Kundu, Ulrich Strych, Federica Giordano, Peter J. Hotez, Maria Elena Bottazzi, Francesca Taraballi, Cristina Poveda
ACS Applied Materials and Interfaces, 2024, 16(13), 15832–15846
Biomimetic Scaffolds Modulate the Posttraumatic Inflammatory Response in Articular Cartilage Contributing to Enhanced Neoformation of Cartilaginous Tissue In Vivo
Guillermo Bauza-Mayol, Marcos Quintela, Ava Brozovich, Michael Hopson, Shazad Shaikh, Fernando Cabrera, Aaron Shi, Federica Banche Niclot, Francesca Paradiso, Emman Combellack, Tom Jovic, Paul Rees, Ennio Tasciotti, Lewis W. Francis, Patrick Mcculloch, Francesca Taraballi
Advanced Healthcare Systems, 2022, 11(1), 2101127
RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is open for submissions.
Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.
Keep up to date with our latest news by following us on LinkedIn or BlueSky. You can also keep informed by signing up to our E-Alerts.